Source link : https://www.newshealth.biz/health-news/spironolactone-shows-mixed-results-in-acute-mi/
The routine administration of spironolactone to patients after a myocardial infarction (MI) did not reduce either of the coprimary outcomes in the CLEAR SYNERGY (OASIS 9) trial. However, there was a suggestion that the mineralocorticoid receptor antagonist may reduce new or worsening heart failure. And although the trial had a high rate of study-drug discontinuation, […]
Author : News Health
Publish date : 2024-11-19 18:00:39
Copyright for syndicated content belongs to the linked Source.
inHealth